S510-1229 Screening compound: N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-1,2,4-oxadiazol-3-yl]pyrrolidine-1-carboxamide

S510-1229 Screening compound: N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-1,2,4-oxadiazol-3-yl]pyrrolidine-1-carboxamide
S510-1229 Screening compound: N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-1,2,4-oxadiazol-3-yl]pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S510-1229
N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-1,2,4-oxadiazol-3-yl]pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S510-1229

Molecular Formula

C19H32N6O4 (C19 H32 N6 O4)

Compound Name

N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-1,2,4-oxadiazol-3-yl]pyrrolidine-1-carboxamide

IUPAC name

N-ethyl-2-[5-(2-{[3-(morpholin-4-yl)propyl]carbamoyl}ethyl)-124-oxadiazol-3-yl]pyrrolidine-1-carboxamide

SMILES

CCNC(N(CCC1)C1c1noc(CCC(NCCCN2CCOCC2)=O)n1)=O

InChI

InChI=1S/C19H32N6O4/c1-2-20-19(27)25-10-3-5-15(25)18-22-17(29-23-18)7-6-16(26)21-8-4-9-24-11-13-28-14-12-24/h15H,2-14H2,1H3,(H,20,27)(H,21,26)/t15-/m0/s1

InChI Key

NTYWDRAZECBYRC-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD31973862

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.5

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

-0.348

Distribution Coefficient, logD

-0.772

Water Solubility, LogSw

-0.74

Polar Surface Area

94.262

Acid Dissociation Constant (pKa)

15.52

Base Dissociation Constant (pKb)

7.62

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

78.95

S510-1229 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S510-1229 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S510-1229?
Check Price and Availability of S510-1229, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S510-1229 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S510-1229
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S510-1229
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S510-1229 available by request